Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Expense Breakdown

EMERGENT BIOSOLUTIONS INC. Expense Breakdown

No Expense Breakdown for EBS on this site yet.

  • 2026-06-30: MCM Products $51.90M; Commercial Products $36.20M.
  • 2025-06-30: MCM Products $25.90M; Commercial Products $36.20M.

Source checked: the stored Expense Breakdown page for EBS.

Expenses by product

Cost of sales: each quarter (3 month)

Quarter endMCM ProductsCommercial Products
2026-06-30$51.90M$36.20M
2025-06-30$25.90M$36.20M

Share-based Payment Arrangement, Expense: each quarter (3 month)

Quarter endMCM ProductsCommercial Products
2026-06-30$700.00K$100.00K
2025-06-30$300.00K

Restructuring Charges: each quarter (3 month)

Quarter endMCM ProductsCommercial Products
2025-06-30-$400.00K$200.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45